327 related articles for article (PubMed ID: 15372674)
21. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.
Das S; Sinha S; Britto R; Somasundaram K; Samuelson AG
J Inorg Biochem; 2010 Feb; 104(2):93-104. PubMed ID: 19913918
[TBL] [Abstract][Full Text] [Related]
23. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
[TBL] [Abstract][Full Text] [Related]
24. Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
Hanif M; Nazarov AA; Hartinger CG; Kandioller W; Jakupec MA; Arion VB; Dyson PJ; Keppler BK
Dalton Trans; 2010 Aug; 39(31):7345-52. PubMed ID: 20601976
[TBL] [Abstract][Full Text] [Related]
25. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
[TBL] [Abstract][Full Text] [Related]
26. Influence of oxygenation on the reactivity of ruthenium-thiolato bonds in arene anticancer complexes: insights from XAS and DFT.
Sriskandakumar T; Petzold H; Bruijnincx PC; Habtemariam A; Sadler PJ; Kennepohl P
J Am Chem Soc; 2009 Sep; 131(37):13355-61. PubMed ID: 19719101
[TBL] [Abstract][Full Text] [Related]
27. DNA structural distortions induced by ruthenium-arene anticancer compounds.
Gossens C; Tavernelli I; Rothlisberger U
J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
[TBL] [Abstract][Full Text] [Related]
28. Controlling the reactivity of ruthenium(II) arene complexes by tether ring-opening.
Pizarro AM; Melchart M; Habtemariam A; Salassa L; Fabbiani FP; Parsons S; Sadler PJ
Inorg Chem; 2010 Apr; 49(7):3310-9. PubMed ID: 20205442
[TBL] [Abstract][Full Text] [Related]
29. Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?
Hanif M; Henke H; Meier SM; Martic S; Labib M; Kandioller W; Jakupec MA; Arion VB; Kraatz HB; Keppler BK; Hartinger CG
Inorg Chem; 2010 Sep; 49(17):7953-63. PubMed ID: 20704358
[TBL] [Abstract][Full Text] [Related]
30. Minor groove site coordination of adenine by platinum group metal ions: effects on basicity, base pairing, and electronic structure.
Amantia D; Price C; Shipman MA; Elsegood MR; Clegg W; Houlton A
Inorg Chem; 2003 May; 42(9):3047-56. PubMed ID: 12716200
[TBL] [Abstract][Full Text] [Related]
31. Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes.
Hu W; Luo Q; Ma X; Wu K; Liu J; Chen Y; Xiong S; Wang J; Sadler PJ; Wang F
Chemistry; 2009 Jul; 15(27):6586-94. PubMed ID: 19533706
[TBL] [Abstract][Full Text] [Related]
32. Osmium(II) and ruthenium(II) arene maltolato complexes: rapid hydrolysis and nucleobase binding.
Peacock AF; Melchart M; Deeth RJ; Habtemariam A; Parsons S; Sadler PJ
Chemistry; 2007; 13(9):2601-13. PubMed ID: 17200926
[TBL] [Abstract][Full Text] [Related]
33. Novel half-sandwich Ru(II)-hydroxamate complexes: synthesis, characterization and equilibrium study in aqueous solution.
Buglyó P; Farkas E
Dalton Trans; 2009 Oct; (38):8063-70. PubMed ID: 19771370
[TBL] [Abstract][Full Text] [Related]
34. Addition of ethynylferrocene to transition-metal complexes containing a chelating 1,2-dicarba-closo-dodecaborane-1,2-dichalcogenolate ligand--in vitro cooperativity of a ruthenium compound on cellular uptake of an anticancer drug.
Wu DH; Wu CH; Li YZ; Guo DD; Wang XM; Yan H
Dalton Trans; 2009 Jan; (2):285-90. PubMed ID: 19089009
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, and antitumor activity of water-soluble (arene)ruthenium(II) derivatives of 1,3-dimethyl-4-acylpyrazolon-5-ato ligands. First example of Ru(arene)(ligand) antitumor species involving simultaneous Ru-N7(guanine) bonding and ligand intercalation to DNA.
Caruso F; Monti E; Matthews J; Rossi M; Gariboldi MB; Pettinari C; Pettinari R; Marchetti F
Inorg Chem; 2014 Apr; 53(7):3668-77. PubMed ID: 24611608
[TBL] [Abstract][Full Text] [Related]
36. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
37. DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes.
Singh SK; Joshi S; Singh AR; Saxena JK; Pandey DS
Inorg Chem; 2007 Dec; 46(25):10869-76. PubMed ID: 18001110
[TBL] [Abstract][Full Text] [Related]
38. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.
Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E
Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.
Wu K; Luo Q; Hu W; Li X; Wang F; Xiong S; Sadler PJ
Metallomics; 2012 Feb; 4(2):139-48. PubMed ID: 22262368
[TBL] [Abstract][Full Text] [Related]
40. G-G base-pairing in nucleobase adducts of the anticancer drug cis-[PtCl2(NH3)(2-picoline)] and its trans isomer.
McGowan G; Parsons S; Sadler PJ
Chemistry; 2005 Jul; 11(15):4396-404. PubMed ID: 15880542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
